Specifically, the FDA has approved semaglutide for adults who are clinically obese (BMI of 30 or higher) or overweight (BMI of 27 or higher) when accompanied by at least one weight-related health condition, such as hypertension, hyperlipidemia, cardiovascular disease, prediabetes, or obstructive sleep apnea
No outcome described in animal research is guaranteed to occur in any human user
ACKNOWLEDGMENTS None NOTES Fig
Programs like Vida Health and Omada offer coaching, digital tools and wellness support to help members develop healthy habits
Were also interested in developing versions of these drugs that specifically target heart capillaries, which could provide cardiac protection with fewer side effects than current formulations, she added
Your doctor can evaluate your health history and determine which option fits your situation